Monoclonal Antibodies
Therapeutic monoclonal antibodies are a leading product of biotechnology, being increasingly used in therapy, and particulary in cancer therapy.
Ten years ago, there were only two monoclonal antibody drugs on the world market, as of 2008 there are 21 FDA approved therapies including eight blockbuster drugs. In 2007, the market was worth $21.9bn and was growing at approximately 15%. PlantFom is developing biosimilar, or generic, versions of a number of marketed monoclonal antibody products.
